Cubist Systematic Strategies’s Idexx Laboratories IDXX Stock Holding History

Cubist Systematic Strategies’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,900	Closed	-$1.02M	–	3244
2025 Q2	$1.02M	Sell	1,900 -2,400	-56%	-$1.15M	﹤0.01%	1938
2025 Q1	$1.81M	Sell	4,300 -3,400	-44%	-$1.48M	0.01%	1488
2024 Q4	$3.18M	Buy	7,700 +7,600	+7,600%	+$3.33M	0.02%	1084
2024 Q3	$50.5K	Sell	100 -5,600	-98%	-$2.72M	﹤0.01%	2764
2024 Q2	$2.78M	Buy	5,700 +3,500	+159%	+$1.76M	0.02%	1129
2024 Q1	$1.19M	Buy	2,200 +2,100	+2,100%	+$1.15M	0.01%	2029
2023 Q4	$55.5K	Buy	+100	New	+$46.9K	﹤0.01%	3261
2023 Q2	–	Sell	-500	Closed	-$250K	–	3884
2023 Q1	$250K	Hold	500	–	–	﹤0.01%	3096
2022 Q4	$204K	Sell	500 -3,800	-88%	-$1.48M	﹤0.01%	3570
2022 Q3	$1.4M	Buy	4,300 +3,000	+231%	+$1.1M	0.01%	2334
2022 Q2	$456K	Buy	+1,300	New	+$530K	﹤0.01%	3122

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Cubist Systematic Strategies's IDXX Position: Q4 2024 in Review

Cubist Systematic Strategies sold out of Idexx Laboratories (IDXX) in Q4 2024, closing a stake of 10,090 shares — an estimated $4.43M sold.

Cubist Systematic Strategies first reported a position in IDXX in Q2 2014 and held it in 38 quarters. The position peaked at $11.5M in Q1 2024. 1,124 funds tracked by Wall St. Rank hold IDXX as of Q4 2024.

Cubist Systematic Strategies reported no remaining Idexx Laboratories position as of Q4 2024 after selling out during the quarter.
Cubist Systematic Strategies sold 10,090 Idexx Laboratories shares in Q4 2024, an estimated $4.43M.
Cubist Systematic Strategies first reported a position in Idexx Laboratories in Q2 2014 and held it in 38 quarters.
Cubist Systematic Strategies's Idexx Laboratories position peaked at $11.5M in Q1 2024.
1,124 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2024.

Based on Cubist Systematic Strategies's 13F filing for Q4 2024, filed 14 Feb 2025.